European Commission grants authorisation for Cinqaero

18-08-2016

European Commission grants authorisation for Cinqaero

koya979 / shutterstock.com

Teva announced today that the European Commission has granted marketing authorisation for Cinqaero (reslizumab) following an efficacy probe.


European Commission, Cinqaero, Teva, EU, reslizumab

LSIPR